Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
GMS VENTURES & INVESTMENTS OTLK Outlook Therapeutics, Inc. 13D/A 16.4% 3mo
Mudrick Capital Management, L.P. EVTL Vertical Aerospace Ltd. 13D/A 64.2% 3mo
POSNER HENRY III PW Power REIT 13D/A 9.3% 3mo
SR One Capital Management, LLC MANE Veradermics, Inc 13D/A 4.9% 3mo
Japan Post Holdings Co., Ltd. AFL Aflac Inc 13G/A 10.15% 3mo
Mithaq Capital SPC PLCE Childrens Place, Inc. 13D/A 61.1% 3mo
Rosalind Advisors, Inc. FEMY Femasys Inc 13G 9.9% 3mo
CAS Investment Partners, LLC HGV Hilton Grand Vacations Inc. 13D 6.5% 3mo
AH Bio Fund IV, L.P. BRVE Braveheart Bio, Inc. 13D 11.4% 3mo
PERCEPTIVE ADVISORS LLC BLSM BlossomHill Therapeutics, Inc. 13G 5.9% 3mo
Chernett Jorey CVRX CVRx, Inc. 13G 5.5% 3mo
Yield Point NY LLC KUST Kustom Entertainment, Inc. 13G 4.3% 3mo
GOLDENTREE ASSET MANAGEMENT LP QVCG QVC Group, Inc. 13D 17.1% 3mo
James N. Topper BRVE Braveheart Bio, Inc. 13G 5.5% 3mo
DART KENNETH BRYAN DKNG DraftKings Inc. 13G 5.8% 3mo
WHITEBOX ADVISORS LLC MERC Mercer International Inc. 13G 5.4% 3mo
Index Venture Associates VI Ltd FIG Figma, Inc. 13G/A 12.3% 3mo
Baron Ren MAAS Maase Inc. 13D/A 14.89% 3mo
Dejun Yu MAAS Maase Inc. 13D/A 14.57% 3mo
ADAR1 Capital Management, LLC NXTC NextCure, Inc. 13G 15.8% 3mo
venBio Global Strategic Fund V, L.P. YARW Yarrow Bioscience, Inc. 13G 9.99% 3mo
Steven F. Urvan POWW Outdoor Holding Co 13D/A 27.5% 3mo
Anthony Brian Goodman MRDN Meridian Holdings Inc. 13D/A 7.45% 3mo
KENNEDY CAPITAL MANAGEMENT LLC OPRX OptimizeRx Corp 13G 6.7% 3mo
CVI Investments, Inc. SCYX Scynexis Inc 13G/A 5.9% 3mo
ORBIMED ADVISORS LLC SPRB Spruce Biosciences, Inc. 13G 4.8% 3mo
Harraden Circle Investments, LLC AACP Apogee Acquisition Corp 13G/A 0% 3mo
ARMISTICE CAPITAL, LLC FBLG FibroBiologics, Inc. 13G 9.99% 3mo
ALLIANCEBERNSTEIN L.P. IMXI International Money Express, Inc. 13G/A 5.1% 3mo
Solas Capital Management, LLC FENC Fennec Pharmaceuticals Inc. 13G/A 5.4% 3mo
Cormorant Asset Management, LP ANL Adlai Nortye Group Ltd. 13G/A 6.77% 3mo
Polar Asset Management Partners Inc. BREZ Breeze Acquisition Corp. II 13G 6.2% 3mo
American Century Investment Management, Inc. CECO Ceco Environmental Corp 13G/A 3.6% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ PEB Pebblebrook Hotel Trust 13G/A 7.6% 3mo
David G. DeWalt HAWK HawkEye 360, Inc. 13G 9.3% 3mo
American Century Investment Management, Inc. TSQ Townsquare Media, Inc. 13G/A 4.9% 3mo
Paradigm Biocapital Advisors LP LXEO Lexeo Therapeutics, Inc. 13G/A 5.3% 3mo
Third Rock Ventures V, L.P. RAPP Rapport Therapeutics, Inc. 13G/A 13.1% 3mo
KING STREET CAPITAL MANAGEMENT, L.P. SGRY Surgery Partners, Inc. 13G 4.6% 3mo
ARMISTICE CAPITAL, LLC SGMOQ Sangamo Therapeutics, Inc 13G/A 9.38% 3mo
American Century Investment Management, Inc. DXC DXC Technology Co 13G/A 6.4% 3mo
MMCAP International Inc. SPC WSTRF Western Uranium & Vanadium Corp. 13G/A 5% 3mo
MMCAP International Inc. SPC SUIG SUI Group Holdings Ltd. 13G/A 8.8% 3mo
James N. Topper AURA Aura Biosciences, Inc. 13G/A 5.6% 3mo
1607 Capital Partners, LLC NIM Nuveen Select Maturities Municipal Fund 13G/A 5.11% 3mo
Alyeska Investment Group, L.P. SKYX SKYX Platforms Corp. 13G/A 1.16% 3mo
MMCAP International Inc. SPC QADR QDRO Acquisition Corp. 13G/A 7.5% 3mo
Harraden Circle Investments, LLC CEPT Cantor Equity Partners II, Inc. 13G/A 0% 3mo
Fort Baker Capital Management LP TONT Graf Global Corp. 13G/A 8.9% 3mo
ORBIMED ADVISORS LLC VTGN Vistagen Therapeutics, Inc. 13G/A 0% 3mo